Recently introduced products.
D000420:Albuterol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D001424:Bacterial Infections / Q000188:drug therapy; D001941:Breast Diseases / Q000188:drug therapy*; D002260:Carboprost / Q000627:therapeutic use*; D020682:Cefixime; D002439:Cefotaxime / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005228:Fatty Acids, Essential / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008041:Linoleic Acids; D031665:Oenothera biennis; D010146:Pain / Q000188:drug therapy*; D010938:Plant Oils; D006473:Postpartum Hemorrhage / Q000188:drug therapy*; D011247:Pregnancy; D000068299:Salmeterol Xinafoate; D017965:gamma-Linolenic Acid
D005228:Fatty Acids, Essential; D008041:Linoleic Acids; D010938:Plant Oils; C028498:evening primrose oil; D000068299:Salmeterol Xinafoate; D017965:gamma-Linolenic Acid; D002260:Carboprost; D020682:Cefixime; D002439:Cefotaxime; D000420:Albuterol